Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

26.02.2024

1 AIDS
6 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
1 Antivir Ther
2 BMC Cancer
1 Cell
1 Clin Infect Dis
3 HIV Med
1 Int J Dermatol
1 J Acquir Immune Defic Syndr
1 J Clin Invest
3 J Infect Dis
3 J Med Virol
1 J Virol
1 Lancet
1 Lancet Infect Dis
2 PLoS Med
8 PLoS One



    AIDS

  1. DEVENDRA A, Kohler M, Letsika M, Khooa H, et al
    HIV viral suppression in children and adolescents two years after transition to dolutegravir: a multicentre cohort study.
    AIDS. 2024 Jan 10. doi: 10.1097/QAD.0000000000003835.
    >> Share


    AIDS Res Hum Retroviruses

  2. LAUFER N, Bouzas MB, Fernandez-Giuliano S, Zapiola I, et al
    Pretreatment HIV-1 Resistance in Argentina: results from the second surveillance study following WHO guidelines (2019).
    AIDS Res Hum Retroviruses. 2024 Feb 22. doi: 10.1089/AID.2023.0083.
    >> Share

  3. XU K, Chen J, Zhu M, Zhang X, et al
    Exploring HIV-1 transmission features among older individuals in developed eastern China.
    AIDS Res Hum Retroviruses. 2024 Feb 22. doi: 10.1089/AID.2023.0066.
    >> Share

  4. DUBE K, Perez-Brumer A, Patel H, Zhou C, et al
    "This is actually a really unique moment in time": Navigating Long-Acting HIV Treatment and HIV Cure Research with Analytical Treatment Interruptions - A Qualitative Interview Study in the United States.
    AIDS Res Hum Retroviruses. 2024 Feb 22. doi: 10.1089/AID.2023.0105.
    >> Share

  5. GULER E, Arikan Sarioglu A, Sultanoglu N, Suer K, et al
    Molecular Epidemiology of HIV-1 Subtypes and Primary Antiretroviral Resistance Profiles in Northern Cyprus: First Data Series.
    AIDS Res Hum Retroviruses. 2024 Feb 17. doi: 10.1089/AID.2023.0021.
    >> Share

  6. KHAYUMBI J, Sasser L, McLaughlin T, Muchiri B, et al
    Active tuberculosis is associated with depletion of HIV-specific CD4 and CD8 T cells in people with HIV.
    AIDS Res Hum Retroviruses. 2024 Feb 17. doi: 10.1089/AID.2023.0088.
    >> Share

  7. SACHDEVA RK, Naidu G, Chauhan P, Kharbanda S, et al
    CSF viral escape on HAART: Analysis from single tertiary care centre.
    AIDS Res Hum Retroviruses. 2024 Feb 17. doi: 10.1089/AID.2022.0187.
    >> Share


    Antimicrob Agents Chemother

  8. MULATO A, Lansdon E, Aoyama R, Voigt J, et al
    Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stability.
    Antimicrob Agents Chemother. 2024 Feb 21:e0137323. doi: 10.1128/aac.01373.
    >> Share


    Antivir Ther

  9. LEPIK KJ, Hunt OL, Bacani N, Wang L, et al
    Adverse drug reactions attributed to generic substitution of antiretroviral medications among HIV treatment and pre-exposure prophylaxis clients in British Columbia, Canada.
    Antivir Ther. 2024;29:13596535241233128.
    >> Share


    BMC Cancer

  10. TAN R, Zhu X, Sun Y, Yang S, et al
    The association of HBV infection and head and neck cancer: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:225.
    >> Share

  11. NAKIGOZI H, Ndejjo R, Bazeyo W, Nabaggala A, et al
    Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda.
    BMC Cancer. 2024;24:243.
    >> Share


    Cell

  12. ARMANI-TOURRET M, Gao C, Hartana CA, Sun W, et al
    Selection of epigenetically privileged HIV-1 proviruses during treatment with panobinostat and interferon-alpha2a.
    Cell. 2024 Feb 16:S0092-8674(24)00105-3. doi: 10.1016/j.cell.2024.
    >> Share


    Clin Infect Dis

  13. AGGARWAL NR, Nordwall J, Braun DL, Chung L, et al
    Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.
    Clin Infect Dis. 2024 Feb 20:ciad780. doi: 10.1093.
    >> Share


    HIV Med

  14. KLEEBAYOON A, Wiwanitkit V
    Asymptomatic monkeypox infection and highly sexually active MSM population.
    HIV Med. 2024 Feb 20. doi: 10.1111/hiv.13623.
    >> Share

  15. RAMOS-RUPERTO L, Arcos-Rueda MDM, de Miguel-Buckley R, Busca-Arenzana C, et al
    Sex differences in the effectiveness and tolerability of dolutegravir plus rilpivirine as a switch strategy in people living with HIV.
    HIV Med. 2024 Feb 20. doi: 10.1111/hiv.13617.
    >> Share

  16. HOLROYD KB, Han WM, Apornpong T, Trautmann L, et al
    Framingham risk score based vascular outcomes in acute versus chronic HIV cohorts after 6 years of ART.
    HIV Med. 2024 Feb 21. doi: 10.1111/hiv.13621.
    >> Share


    Int J Dermatol

  17. TYAGI M, Verma V, Bhari N, Gupta S, et al
    Herpes presenting as pyoderma gangrenosum-like ulcers in a child with AIDS.
    Int J Dermatol. 2024;63:371-373.
    >> Share


    J Acquir Immune Defic Syndr

  18. GRIESEL R, Banda CG, Zhao Y, Omar Z, et al
    PHARMACOKINETICS OF SINGLE VERSUS DOUBLE-DOSE DOLUTEGRAVIR AFTER SWITCHING FROM A FAILING EFAVIRENZ-BASED REGIMEN.
    J Acquir Immune Defic Syndr. 2024 Feb 15. doi: 10.1097/QAI.0000000000003402.
    >> Share


    J Clin Invest

  19. GASCA-CAPOTE C, Lian X, Gao C, Roseto IC, et al
    The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers.
    J Clin Invest. 2024 Feb 20:e174215. doi: 10.1172/JCI174215.
    >> Share


    J Infect Dis

  20. PIHL RMF, Smith-Mahoney EL, Olson A, Yuen RR, et al
    Distinct subsets of Vdelta1 effector and Vdelta2 gammadelta T cells shift in frequency and are linked to plasma inflammatory markers during ART-suppressed HIV infection.
    J Infect Dis. 2024 Feb 23:jiae091. doi: 10.1093.
    >> Share

  21. THIELE RJ, Grunhagel B, Muenchhoff M, Pujantell-Graell M, et al
    Magnitude of Type I Interferon Responses by Plasmacytoid Dendritic Cells After TLR7 Stimulation Is Associated With Human Immunodeficiency Virus Type 1 (HIV-1) Reservoir Sizes in Cisgender Women With HIV-1 on Antiretroviral Therapy.
    J Infect Dis. 2024 Feb 22:jiae013. doi: 10.1093.
    >> Share

  22. SHIAU S, Zumpano F, Wang Z, Shah J, et al
    Epigenetic Aging and Musculoskeletal Outcomes in a Cohort of Women Living With HIV.
    J Infect Dis. 2024 Feb 15:jiae016. doi: 10.1093.
    >> Share


    J Med Virol

  23. XU Y, Jiao K, Zhang Y, Huang S, et al
    Behavioral intentions of self-isolation and informing close contacts after developing mpox-related symptoms among young men who have sex with men in China.
    J Med Virol. 2024;96:e29470.
    >> Share

  24. DEL PINO M, Vorsters A, Joura EA, Doorbar J, et al
    Risk factors for human papillomavirus infection and disease: A targeted literature summary.
    J Med Virol. 2024;96:e29420.
    >> Share

  25. SERWIN K, Scheibe K, Urbanska A, Aksak-Was B, et al
    Phylodynamic evolution of HIV-1 A6 sub-subtype epidemics in Poland.
    J Med Virol. 2024;96:e29482.
    >> Share


    J Virol

  26. FENTON AD, Archin N, Turner A-M, Joseph S, et al
    A novel high-throughput microwell outgrowth assay for HIV-infected cells.
    J Virol. 2024 Feb 20:e0179823. doi: 10.1128/jvi.01798.
    >> Share


    Lancet

  27. JOHNSTONE F
    Picture an epidemic: contemporary culture and HIV.
    Lancet. 2024 Feb 13:S0140-6736(24)00252-6. doi: 10.1016/S0140-6736(24)00252.
    >> Share


    Lancet Infect Dis

  28. ALLAN-BLITZ LT, Fifer H, Klausner JD
    Managing treatment failure in Neisseria gonorrhoeae infection: current guidelines and future directions.
    Lancet Infect Dis. 2024 Feb 14:S1473-3099(24)00001.
    >> Share


    PLoS Med

  29. SEMITALA FC, Kadota JL, Musinguzi A, Welishe F, et al
    Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.
    PLoS Med. 2024;21:e1004356.
    >> Share

  30. MATHUR S, Smuk M, Evans C, Wedderburn CJ, et al
    Estimating the impact of alternative programmatic cotrimoxazole strategies on mortality among children born to mothers with HIV: A modelling study.
    PLoS Med. 2024;21:e1004334.
    >> Share


    PLoS One

  31. RUNGMAITREE S, Werarak P, Pumpradit W, Phongsamart W, et al
    A pilot program of HIV pre-exposure prophylaxis in Thai youth.
    PLoS One. 2024;19:e0298914.
    >> Share

  32. MUDRA RAKSHASA-LOOTS A, Naidoo S, Hamana T, Fanqa B, et al
    Multi-modal analysis of inflammation as a potential mediator of depressive symptoms in young people with HIV: The GOLD depression study.
    PLoS One. 2024;19:e0298787.
    >> Share

  33. LIKOTI PG, Kuupiel D, Khuzwayo N
    Mapping factors influencing initiation of antiretroviral treatment among adolescents living with HIV/AIDS in sub-Saharan Africa: A scoping review protocol.
    PLoS One. 2024;19:e0289515.
    >> Share

  34. MESIC A, Decroo T, Mar HT, Jacobs BKM, et al
    Correction: Viraemic-time predicts mortality among people living with HIV on second-line antiretroviral treatment in Myanmar: A retrospective cohort study.
    PLoS One. 2024;19:e0299460.
    >> Share

  35. NYMAN F
    Reshaping the narrative: Tracing the historical trajectory of HIV/AIDS, gay men, and public health in Sweden.
    PLoS One. 2024;19:e0298630.
    >> Share

  36. KAMAU SG, Akatusasira R, Namatovu A, Kibet E, et al
    The level of antiretroviral therapy (ART) adherence among orphan children and adolescents living with HIV/AIDS: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0295227.
    >> Share

  37. STANTON AM, Boyd RL, O'Cleirigh C, Olivier S, et al
    HIV, multimorbidity, and health-related quality of life in rural KwaZulu-Natal, South Africa: A population-based study.
    PLoS One. 2024;19:e0293963.
    >> Share

  38. CONAN N, Simons E, Chihana ML, Ohler L, et al
    Correction: Increase in HIV viral suppression in KwaZulu-Natal, South Africa: Community-based cross sectional surveys 2018 and 2013. What remains to be done?
    PLoS One. 2024;19:e0299408.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016